Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.

 Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday 14th August 2023 inter alia, to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2023. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.
05-08-2023
Bigul

Shree Ganesh Biotech (India) Ltd - 539470 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please Find Enclosed.
04-07-2023
Bigul

Shree Ganesh Biotech (India) Ltd - 539470 - Closure of Trading Window

 Please Find Enclosed.
30-06-2023
Bigul

Shree Ganesh Biotech (India) Ltd - 539470 - Announcement under Regulation 30 (LODR)-Cessation

 We have attached the resignation letter along with documents for the same. Thanking You.
30-06-2023
Bigul

Shree Ganesh Biotech (India) Ltd - 539470 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed copies of the newspaper publication pertaining to the extract of the financial results of the Company for the quarter and year ended on 31st March 2023. The said extract of the financial results was published in The Echo of India (In English - All India edition) The Arthik Lipi in Bengali (Kolkata Edition) on 31st May 2023. This is for your information and records. This will also be hosted on Company's website at https:// www.shreeganeshbiotech.club /announcement/ Thanking You.
31-05-2023
Bigul

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

 Pursuant to SEBI Circular - CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding statement on Deviation or variation for proceeds of public issue/Rights Issue/preferential issue, Qualified institutional placement (QIP) etc., read with Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform that: The Company does not have any funds remaining unutilised as on 31st March 2023, or as on date, out of the proceeds of public issue/Rights Issue/preferential issue, qualified institutional placement (QIP) etc., if any undertaken by it at anytime in the past. In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the said Regulation / Circular. This is for your information and records. Thanking You.
30-05-2023
Bigul

Shree Ganesh Biotech (India) Ltd - 539470 - Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 This is to inform you that Outcome of the Board Meeting of the Company held on Tuesday 30th May 2023 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2023. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2023. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2023 with unmodified opinion. The board meeting concluded on 05:00 P.M. Request you to kindly take on record the same. Thanking You.
30-05-2023
Bigul

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 30Th May 2023.

 This is to inform you that Outcome of the Board Meeting of the Company held on Tuesday 30th May 2023 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2023. 2.) Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulations, 2015 for the F.Y. 31st March, 2023. Further, we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2023 with unmodified opinion. The board meeting concluded on 05:00 P.M. Request you to kindly take on record the same. Thanking You.
30-05-2023
Bigul

Annual report for Shree Ganesh Bio-Tech (India) Ltd. for FY-2023
30-05-2023
Bigul

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.

 Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 30th May 2023 at registered office of the company inter alia, to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 31st March 2023. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You.
23-05-2023
Next Page
Close

Let's Open Free Demat Account